The choice of drug from the standpoint of evidence-based medicine: case study of beta-blockers

被引：0
|
作者：
Martsevich, S. Yu. [1 ,2 ]
Kutishenko, N. P. [1 ]
Lukina, Yu. V. [1 ,2 ]
机构：
[1] State Res Ctr Prevent Med, Petroverigsky Per 10, Moscow 101990, Russia
[2] IM Setchenov First Moscow State Med Univ, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2010年 / 6卷 / 06期
关键词：
drug choice; cardiovascular risk; beta-blockers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases. Beta-blocker indications and safety of their long-term use are considered from this point of view. Convincing data about beta-blocker impact on the prognosis of cardiovascular disease should be the reason for any beta-blocker choice, as well as choice of their doses which were tested in large randomized trials.
引用
收藏
页码：876 / 881
页数：6
相关论文
共 30 条
  • [1] Beta-blockers and arterial hypertension. Evidence-based medicine or excessive fury?
    Verdecchia, Paolo
    Angeli, Fabio
    Achilli, Paola
    Castellani, Claudia
    Repaci, Salvatore
    Ambrosio, Giuseppe
    GIORNALE ITALIANO DI CARDIOLOGIA, 2007, 8 (09) : 552 - 558
  • [2] Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review
    Xu, Shi-Qiong
    Jia, Ren-Bing
    Zhang, Wei
    Zhu, Huang
    Ge, Sheng-Fang
    Fan, Xian-Qun
    WORLD JOURNAL OF PEDIATRICS, 2013, 9 (03) : 221 - 229
  • [3] Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review
    Shi-Qiong Xu
    Ren-Bing Jia
    Wei Zhang
    Huang Zhu
    Sheng-Fang Ge
    Xian-Qun Fan
    World Journal of Pediatrics, 2013, 9 : 221 - 229
  • [4] Beta-blockers in heart failure - The evidence from clinical trials
    Hampton, JR
    EUROPEAN HEART JOURNAL, 1996, 17 : 17 - 20
  • [5] Impact of an Acute Coronary Syndrome Pathway in Achieving Target Heart Rate and Utilization of Evidence-Based Doses of Beta-Blockers
    Irani, Farzan
    Herial, Nabeel
    Colyer, William R., Jr.
    AMERICAN JOURNAL OF THERAPEUTICS, 2012, 19 (06) : 397 - 402
  • [6] Beta-blockers in the treatment of arterial hypertension: evidence based data and real practice
    Leonova, M. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (01) : 75 - 80
  • [7] How Beta-Blockers Are Used in Spain? Analysis of Limitations in Their Use in Internal Medicine and Cardiology: CARACTER-BETA Study
    Garcia-Moll, Xavier
    Facila, Lorenzo
    Conthe, Pedro
    Zapata, Antonio
    Artigas, Remei
    Bertomeu, Vicente
    Ramon Gonzalez-Juanatey, Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (10): : 883 - 890
  • [8] A comparative ex vivo drug permeation study of beta-blockers through porcine buccal mucosa
    Amores, Sonia
    Lauroba, Jacinto
    Calpena, Ana
    Colom, Helena
    Gimeno, Alvaro
    Domenech, Jose
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) : 50 - 54
  • [9] Pulmonary safety of ophthalmic beta-blockers: a nationwide registry-based cohort study
    Kristensen, Mathias L.
    Simonsen, Jan H.
    Torp-Pedersen, Christian
    Vorum, Henrik
    Aasbjerg, Kristian
    ACTA OPHTHALMOLOGICA, 2018, 96 (07) : 705 - 711
  • [10] Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study
    Saad, Akram
    Goldstein, Jeffrey
    Margalit, Ofer
    Shacham-Shmueli, Einat
    Lawrence, Yaacov R.
    Yang, Yu-Xiao
    Reiss, Kim A.
    Golan, Talia
    Mamtani, Ronac
    Halpern, Naama
    Aderka, Dan
    Mouallem, Meir
    Goldstein, Adam
    Giantonio, Bruce
    Boursi, Ben
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (05) : 599 - 604
123